IN THE NEWS
BD and Decode Health: Innovating to bring molecular tests to patients’ homes
We’re excited to announce the BD and Decode Health strategic partnership that will accelerate innovation and advance precision medicine. Together, we’re working to advance at home collections for molecular biomarkers like RNA using a simple finger stick. Our work could unlock groundbreaking innovations for biomarker discovery and routine screening across multiple disciplines from oncology to autoimmune diseases and beyond. At-home testing can significantly improve efficiency and enhance diversity in clinical trials, speeding the development of potentially life-saving treatments.
Decode Health Recognized as the 2022 Emerging Healthcare NEXT Awards Winner
Decode Health was recently honored for its commitment to advancing precision medicine and extraordinary promise for future endeavors with a 2022 Nashville Entrepreneur Center NEXT Award for healthcare innovation.
NIH Awards Decode Health $248K Grant to Detect and Distinguish Progressive Forms of Multiple Sclerosis
Decode Health today announced it received a $248,000 one year grant from the National Institutes of Health (NIH) to create new methods to distinguish relapsing-remitting and progressive forms of multiple sclerosis (MS).
